Nariko Ikemura

An engineered ACE2 decoy neutralizes the SARS-CoV-2 Omicron variant and confers protection against infection in vivo

K. Katoh, D. Standley, D. Motooka, 2022, Science Translational Medicine.

Proximal balloon occlusion to prevent downstream embolization and thus reduce systemic adverse effects of drug-coated balloons

T. Sawada, J. Shiraishi, M. Hyogo, 2019, Cardiovascular Intervention and Therapeutics.

Engineering ACE2 decoy receptors to combat viral escapability

D. Standley, T. Okamoto, A. Hoshino, 2022, Trends in Pharmacological Sciences.

Optical frequency domain imaging-guided stent-less percutaneous coronary intervention using rotational atherectomy to the calcified nodule.

Tetsuro Nishimura, T. Sawada, J. Shiraishi, 2020, Coronary artery disease.

Optical Frequency Domain Images of 3 Unique Femoral Artery Stents at 5 Months After Implantation.

T. Sawada, M. Kimura, Jun Yoshimura, 2021, JACC. Cardiovascular interventions.

Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2

J. Takagi, Y. Matsuura, D. Motooka, 2021, Nature Communications.

High affinity modified ACE2 receptors prevent SARS-CoV-2 infection

J. Takagi, Y. Matsuura, D. Motooka, 2020, bioRxiv.

Engineered ACE2 counteracts vaccine-evading SARS-CoV-2 Omicron variant

K. Katoh, J. Takagi, D. Standley, 2021, bioRxiv.

Deep mutational scanning of whole SARS-CoV-2 spike in an inverted infection system

D. Standley, D. Motooka, Y. Kirita, 2023, bioRxiv.

Angiographic and clinical outcomes after stent-less coronary intervention using rotational atherectomy and drug-coated balloon in patients with de novo lesions.

Tetsuro Nishimura, T. Sawada, Akiteru Kojima, 2020, Cardiovascular revascularization medicine : including molecular interventions.